We are looking for a full-stack expert. You have taken multiple apps from conception to deployment, and have experience and opinions on the best technologies to use and why. You should be comfortable implementing new features from scratch, making changes to existing features and writing complex migrations on production data. You should be able to hit the ground running and be able to read code to figure out how it should work, how it currently works, and how best to improve it.
We are a remote-first company, with an office in San Francisco. Half of our 8-person team are remote. We meet up for offsite retreats bi-annually, previously we have skied near Tahoe and tasted wine in Sonoma. Our Employee Handbook is published here: https://github.com/EnzymeCorp/handbook
Enzyme is a Y Combinator company (YC S17), with 30+ paying customers, and we are growing our team to keep up with demand. This is an opportunity to be an early engineer at a startup that has found its feet and shape the engineering culture, and you should have opinions on how to do that.
If you enjoy working with smart and kind people, want to work for a company with a goal to improve peoples' lives and want an opportunity to both grow with a company and shape that company's growth, we want to hear from you.
- Excellent verbal and written communication skills
- “Strong opinions, weakly held”
- Experience in Ember, React or other SPA frameworks, AWS, Terraform
- Experience working within life science or another regulated industry.
- Experience working within a distributed team
Annual Salary $110,000 - $190,000
Equity 0.25% - 1%
What We’re Building
Think TurboTax, but for the FDA.
We’re building a software platform to handle the compliance aspects of running a drug or medical device company. Compliance is an ongoing activity for companies in this space, and annual costs per company range anywhere from $100K to $100M. Being deemed not compliant can be devastating, preventing a company from selling any new product for months and sometimes years.
In lieu of hiring costly consultants or employees to address this problem, customers provide our platform access to their data, and the platform outputs documentation in the manner that FDA and other regulatory agencies are looking for.
By using our software platform, customers will cut their annual regulatory costs by 50% (on average) and reduce the risk that their products will not get approved for sale.
Imagine a world in which every new piece of medical technology -- every new chemo drug, pacemaker, Alzheimer’s therapy -- gets in the hands of patients 30% faster. That’s the world we’re building. And we’re looking for people who are motivated by the idea of being a force multiplier across an industry, and thus having a small hand in every new exciting technology being developed over the next 10 years.
Enzyme is enabling the next generation of biomedical technology by building FDA approval as a service. Our software allows our customers to get their products to market faster, with less capital and less risk of getting denied by FDA. Our mission is to ensure that no product ever fails to succeed because of regulatory issues.
We’re backed by YCombinator, Refactor Capital, Data Collective and Rock Health.